• Company
• "C-Trelin proven effective for SCD treatment…reimb needed"
• by Lee, Seok-Jun Jan 22, 2025 05:55am

• Company
• "Foreign drug price re-evaluation, unfair direct comparison"
• by Kim, Jin-Gu Jan 22, 2025 05:54am

• Company
• Leqembi may be prescribed in general hospitals in Korea
• by Eo, Yun-Ho Jan 22, 2025 05:54am

• Policy
• MOHW to 'carefully review' post-dispensing notification law
• by Lee, Jeong-Hwan Jan 22, 2025 05:54am

• Company
• HK Inno.N and Roche will co-promote Avastin
• by Chon, Seung-Hyun Jan 22, 2025 05:54am

• Policy
• Yuyu seeks to expand the scope of its fexofenadine to ETC
• by Lee, Tak-Sun Jan 21, 2025 05:54am

• Policy
• CKD completes acquisition of diabetes drug 'Januvia'
• by Lee, Tak-Sun Jan 21, 2025 05:54am

• Policy
• MFDS approves Vyvgart for severe myasthenia gravis
• by Lee, Hye-Kyung Jan 21, 2025 05:54am

• Policy
• MFDS' pharma policy keyword, 'shorten time'
• by Lee, Hye-Kyung Jan 21, 2025 05:54am

• Company
• Astellas 'Xtandi' offers high efficacy with low side effects
• by Whang, byung-woo Jan 21, 2025 05:54am